SensaSure Technologies and Verde Bio Holdings Provide Update on Pending Merger
Registration Statement on Form S-4 Declared Effective by the Securities and Exchange Commission Special Meeting of SensaSure and Verde Stockholders to be held on May 9, 2024 Merger Expected to Close by the end of May 2024 LAS VEGAS, NV, April 24, 2024– SensaSure Technologies, Inc. (OTCQB: SSTC) (“SensaSure”) and Verde Bio Holdings, Inc. (OTC: VBHI) […]
BranchOut Food Announces Third Contract with Nation’s Largest Retailer, to Total $8M in Annualized Revenue
New commitment valued at $300,000 brings total annualized value to over $8M BranchOut Food’s dried fruit products expected to enter 1,400 stores in September 2024 BEND, Ore., April 24, 2024 – BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced it has expanded its […]
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
Strategic Audit Completion Set to Enhance BioStem Technologies’ Market Position and Shareholder Value POMPANO BEACH, FLORIDA, April 24, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced the successful completion of comprehensive audits for fiscal years 2022 and 2023. This completion is […]
Rodedawg Ind. Intl., Inc. Announces New Officers Appointment for Elixicure, LLC
Rodedawg enters into 11 Billion dollar topical pain relief market COSTA MESA, CA, April 23, 2024 - Rodedawg International Industries, Inc. (OTC: RWGI) is pleased to announce the appointment of new officers to lead its subsidiary, Elixicure, Inc. Chris Swartz, CEO, states: “Last year, Rodedawg acquired Elixicure’s assets of brands, manufacturing equipment, trade secrets, and […]
SS Innovations International Announces Q1 2024 Company Updates
Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, FL, April 22, 2024 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced its Q1 2024 Company […]
American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione
SAN FRANCISCO, CA, April 12, 2024 – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announces the sudden passing of its Chief Executive Officer, Peter Gaccione. Ray Stachowiak, Executive Chairman of American Shared Hospital Services, said, […]
ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS
Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 12, 2024 – Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the year ended December 31, 2023. Recent Highlights “In 2023, we made significant progress on cost controls and in the development of […]
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
IRVINE, CA, April 11, 2024 – Oncocyte Corporation (NASDAQ: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into definitive securities purchase agreements (the “Purchase Agreements”) for the purchase and sale of an aggregate of 5,077,387 shares of common stock, at a purchase price of $ 2.9164 per share […]
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
– Bio-Rad expects to make equity investment in support of deal – Agreement provides for global exclusivity in transplant monitoring commercialization – Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, CA, April 11, 2024 – Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced a partnership agreement with Bio-Rad Laboratories (NYSE: BIO), a […]
Auto Parts 4 Less Group Inc. Announces Strategic Investment from RB Capital to Fuel Growth and Innovation
Las Vegas, NV, April 11, 2024 – Auto Parts 4 Less Group, Inc. (OTC: FLES) (“AutoParts4Less,” “the Company”), a technology-driven e-commerce leader in the automotive parts sector, announces Investment from RB Capital. AutoParts4Less is excited to announce today that it has completed the first tranche of funding from RB Capital Partners, following the successful restructuring […]